I Mab Correlations
IMAB Stock | USD 1.01 0.05 4.72% |
The current 90-days correlation between I Mab and Puma Biotechnology is 0.07 (i.e., Significant diversification). The correlation of I Mab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
I Mab Correlation With Market
Average diversification
The correlation between I Mab and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding I Mab and DJI in the same portfolio, assuming nothing else is changed.
IMAB |
Moving together with IMAB Stock
Moving against IMAB Stock
0.57 | DYAI | Dyadic International | PairCorr |
0.37 | PTN | Palatin Technologies | PairCorr |
0.36 | BMY | Bristol Myers Squibb | PairCorr |
0.36 | GILD | Gilead Sciences | PairCorr |
0.34 | ESPR | Esperion Therapeutics | PairCorr |
0.59 | MNMD | Mind Medicine | PairCorr |
0.44 | ABCL | Abcellera Biologics | PairCorr |
0.31 | MOLN | Molecular Partners | PairCorr |
0.55 | TARS | Tarsus Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IMAB Stock performing well and I Mab Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze I Mab's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PBYI | 2.83 | 0.50 | 0.07 | (8.70) | 4.36 | 5.17 | 33.65 | |||
IOVA | 3.23 | (0.26) | 0.00 | (0.01) | 0.00 | 7.54 | 23.06 | |||
SRPT | 1.75 | (0.09) | (0.05) | 0.01 | 2.17 | 3.75 | 17.87 | |||
DAWN | 2.02 | (0.22) | 0.00 | (0.12) | 0.00 | 3.71 | 11.05 | |||
INZY | 3.05 | (0.95) | 0.00 | (0.61) | 0.00 | 6.76 | 16.62 | |||
ZNTL | 4.19 | 0.01 | 0.03 | 0.12 | 5.10 | 11.41 | 33.76 | |||
SNDX | 2.39 | (0.30) | 0.00 | (0.70) | 0.00 | 4.02 | 34.00 | |||
PTGX | 1.96 | (0.10) | 0.00 | (0.51) | 0.00 | 3.42 | 16.19 | |||
MRSN | 4.66 | 0.86 | 0.14 | 1.11 | 4.75 | 12.03 | 32.25 |
I Mab Corporate Management
Louie MD | Interim Officer | Profile | |
Richard MBA | COO CFO | Profile | |
Weiming Tang | Executive Officer | Profile | |
Jerry Wang | CoFounder Officer | Profile | |
Cheng Li | Chief Officer | Profile | |
Skelton Joseph | Chief Officer | Profile |